Human Recombinant EGF G5021

From ToxBankWiki

Human Recombinant EGF G5021
Jump to: navigation, search

Human Recombinant Epidermal Growth Factor (G5021)

Molecular Description

Molecular Weight 6.2kDa
Glycosylation

Biological Source

Name E. Coli
Recombinant or animal source Recombinant.

Characterisation Data

PAGE with antibodies
Cell culture testing e.g. growth promotion, cytokine expression

Quality Control Parameters

Biological assay/activity Biological Activity: The ED50 for rhEGF, i.e., the concentration of factor that produces one-half the maximal response, isdetermined in a proliferation bioassay using BALB/c 3T3 fibroblasts in serum-free medium and the CellTiter 96® AQueousNon-Radioactive Cell Proliferation Assay (Cat.# G5421). The ED50 value obtained is reported on the Product InformationLabel affixed to this document.Specific Activity: An international reference standard 91/530 for recombinant EGF, provided by the National Institute forBiological Standards and Controls, is run in parallel with each batch of rhEGF and used to assign the specific activity.

Company Product Link
Promega Promega(G5021)

Authors of this ToxBank wiki page

David Bower, Glenn Myatt
Personal tools
Namespaces
Variants
Actions
Navigation
Hepatotoxins
Cardiotoxins
Renal Toxins
Special Substances
Undifferentiated Stem Cells
hiPSC Lines
Liver Cell Lines
iPS-derived Cardiomyocytes
Reagents (Growth Factors)
Reagents (Antibodies)
Reagents (Others)
Suppliers (Cells)
Toolbox